Navigation Links
Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost & Sullivan
Date:4/10/2013

LONDON, April 10, 2013 /PRNewswire/ -- The rise in the number of minimally invasive surgeries (MIS) is promoting the use of endoscopy devices. These devices provide the necessary visualisation during MIS procedures.

New analysis from Frost & Sullivan (http://www.medtech.frost.com), Western European Endoscopy Devices Market, finds that the market earned revenues of $2.96 billion in 2012 and estimates this to reach $4.44 billion in 2019. The research covers the potential for rigid and flexible endoscopes and endoscopy equipment and accessories across applications in arthroscopy, ENT, gastrointestinal, gynaecology, laparoscopy, neurology, pulmonary and urology.

"In the existing managed care environment, MIS procedures – which offer both clinical and cost benefits – are increasing at a faster pace than conventional surgical procedures," notes Frost & Sullivan Healthcare Research Analyst Brahadeesh Chandrasekaran. "This is expected to be a key driving factor for endoscopy devices."

Endoscopy's advantage over traditional surgery is attributed to its ability to provide a visual, while being minimally invasive. This is motivating the use of these devices in various surgical techniques. For instance, endoscopy techniques such as arthroscopy, a major surgical endoscopic technique that focused primarily on the knee, is now expanding to other areas such as the shoulder, the wrist and small peripheral joints.

Endoscopy has become a common procedure in various fields such as urology, gynaecology and gastroenterology. In the future, endoscopy may be the standard procedure for the diagnosis and treatment of most internal organ disorders, as well as for the treatment of liver, colorectal and other types of cancer.

"The sale of technologically advanced products, such as video-endoscopes and capsule endoscopes, indicate that there is a huge demand for advanced, innovative products," adds Chandrasekaran. "Although these devices are initially challenged by the lack of reimbursement, penetration levels are set to rise subsequent to strong clinical evidence being provided."

On the competitive front, the Western European endoscopy devices market is highly consolidated and dominated by large multinational companies. This makes market penetration difficult for new or small companies.

"The main strategy of big multinationals is the early introduction of innovative next-generation endoscopes and devices; being first-to-market ensures high revenues as there is a little pricing pressure due to the lack of competition," states Chandrasekaran. "Small companies are focusing on specialisation and are establishing themselves strongly in niche segments."

If you are interested in more information on this research, please send an email to Anna Zanchi , Corporate Communications, at anna.zanchi@frost.com

Western European Endoscopy Devices Market is part of the Advanced Medical Technologies Growth Partnership Service programme. Frost & Sullivan's related research services include: Western European Dental Implants Market, Medical Device Industry – Recovering from Recession, and European Orthopaedic Devices Market Outlook. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on "the next big thing"
Register:         Gain access to visionary innovation

Contact
Anna Zanchi
Corporate Communications – Europe
P: 0039 02 46514819
E: anna.zanchi@frost.com
http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Outlook for Medical Devices in Western Europe
2. Western Pain Society Galvanizes Coalition to Launch the Alliance for Rational Use of NSAIDs
3. ProteinSimple Charges Ahead with the Simple Western
4. Skin Integrity Products (SIP): Effective Distribution Networks Are Key to Penetrating Western European Market, Says Frost & Sullivan
5. The Outlook for Pharmaceuticals in Western Europe
6. Millennium Research Group Sponsors Case Competition at Western University for Second Year
7. Western Maryland Health System Expands Use of Versus RTLS to Enhance Staff Safety
8. Boston Scientific Announces CE Mark and European Launch of Emergeā„¢ PTCA Dilatation Catheter
9. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
10. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
11. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):